Michael E. Perlman

2.0k citations

32 papers · 1.7k indexed · h-index 16

Impact in

Developmental Neuroscience top 5%
Pathology and Forensic Medicine top 5%
- Cardiac Ischemia and Reperfusion

Papers in ⓘ

Molecular Biology 13
- Biochemical and Molecular Research 5
- Ion channel regulation and function 4
Organic Chemistry 12
- Synthesis and Characterization of Heterocyclic Compounds 5
- Synthesis and Catalytic Reactions 4

Co-authors: Robert E. London (8 shared papers)Charles Steenbergen (2 shared papers)Elizabeth Murphy (2 shared papers)D. G. Davis (1 shared paper)Donald G. Davis (3 shared papers)Ronald W. Clark (1 shared paper)M J Bamberger (1 shared paper)Tamara A. Sutfin (1 shared paper)
Journals: Journal of Medicinal Chemistry (5 papers)Biochemistry (4 papers)Circulation Research (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Pharmacology (2 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Michael E. Perlman

32 papers receiving 1.6k citations

Peers

Countries citing papers authored by Michael E. Perlman

Since Specialization

Citations

This map shows the geographic impact of Michael E. Perlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Perlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Perlman more than expected).

Fields of papers citing papers by Michael E. Perlman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Perlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Perlman. The network helps show where Michael E. Perlman may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Perlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Perlman Line = papers co-authored together Michael E. Perlman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mechanism of preconditioning. Ionic alterations. Circulation Research ·Charles Steenbergen, Michael E. Perlman, Robert E. London, Elizabeth Murphy	1993	292
2	Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein Arteriosclerosis Thrombosis and Vascular Biology ·Ronald W. Clark, Tamara A. Sutfin, Roger B. Ruggeri, Ann T. Willauer, Eliot Sugarman, George Magnus-Aryitey, Patricia G. Cosgrove, Thomas Sand, Ronald T. Wester, John A. Williams, Michael E. Perlman, M J Bamberger	2004	283
3	Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circulation Research ·Elizabeth Murphy, Michael E. Perlman, Robert E. London, Charles Steenbergen	1991	269
4	Direct Measurements of the Dissociation-Rate Constant for Inhibitor-Enzyme Complexes via the T1ρ and T2 (CPMG) Methods Journal of Magnetic Resonance Series B ·D. G. Davis, Michael E. Perlman, Robert E. London	1994	255
5	Relaxation-matrix analysis of the transferred nuclear overhauser effect for finite exchange rates Journal of Magnetic Resonance (1969) ·Robert E. London, Michael E. Perlman, Donald G. Davis	1992	71
6	Development of a self-emulsifying formulation that reduces the food effect for torcetrapib International Journal of Pharmaceutics ·Michael E. Perlman, Sharad B. Murdande, Mike Gumkowski, Tejas Shah, Charlotte Coretta Rodricks, Janice R. Thornton‐Manning, D FREEL, L ERHART	2007	63
7	Nucleosides. 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents Journal of Medicinal Chemistry ·Michael E. Perlman, Kyoichi A. Watanabe, Raymond F. Schinazi, Jack J. Fox	1985	46
8	Dissociation constants for dihydrofolic acid and dihydrobiopterin and implications for mechanistic models for dihydrofolate reductase Biochemistry ·Geeta Maharaj, Barry S. Selinsky, James R. Appleman, Michael E. Perlman, Robert E. London, Raymond L. Blakley	1990	45
9	Synthesis and binding characteristics of N-(1-naphthyl)-N′-(3-[125I]-iodophenyl)-N′-methylguanidine ([125I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation Nuclear Medicine and Biology ·Jonathan Owens, Andrew A Tebbutt, Ailsa L. McGregor, Kazuya Kodama, Sharad S. Magar, Michael E. Perlman, David J. Robins, Graham J. Durant, James McCulloch	2000	42
10	Design, Synthesis, and Pharmacological Evaluation of Conformationally Constrained Analogues of N,N‘-Diaryl- and N-Aryl-N-aralkylguanidines as Potent Inhibitors of Neuronal Na⁺ Channels Journal of Medicinal Chemistry ·Michel Maillard, Michael E. Perlman, Oved Amitay, Deborah F. Baxter, David Berlove, Sonia Connaughton, James B. Fischer, Jun Guo, Lain‐Yen Hu, Robert McBurney, Peter I. Nagy, Katragadda Subbarao, Elizabeth A. Yost, Lu Zhang, Graham J. Durant	1998	41
11	Neuroprotective Use‐Dependent Blockers of Na⁺ and Ca²⁺ Channels Controlling Presynaptic Release of Glutamate^a Annals of the New York Academy of Sciences ·Stanley M. Goldin, Katragadda Subbarao, Rahul Sharma, Andrew Knapp, James B. Fischer, Deborah Daly, Graham J. Durant, N. Laxma Reddy, Lain‐Yen Hu, Sharad S. Magar, Michael E. Perlman, Jun Chen, Steven H. Graham, William F. Holt, David Berlove, LEE D. MARGOLIN	1995	26
12	Carbon-13 and nitrogen-15 nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductase Biochemistry ·Barry S. Selinsky, Michael E. Perlman, Robert E. London, Clifford J. Ünkefer, John B. O. Mitchell, Raymond L. Blakley	1990	23
13	Uridine diphospho sugars and related hexose phosphates in the liver of hexosamine-treated rats: identification using phosphorus-31-{proton} two-dimensional NMR with HOHAHA relay Biochemistry ·Michael E. Perlman, Donald G. Davis, Scott A. Gabel, Robert E. London	1990	21
14	Studies of Inhibitor Binding to Escherichia coli Purine Nucleoside Phosphorylase Using the Transferred Nuclear Overhauser Effect and Rotating-Frame Nuclear Overhauser Enhancement Biochemistry ·Michael E. Perlman, Donald G. Davis, George W. Koszalka, Joel V. Tuttle, Robert E. London	1994	19
15	In vitro–in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623 European Journal of Pharmaceutics and Biopharmaceutics ·Claire L. McEvoy, Natalie L. Trevaskis, Glenn A. Edwards, Michael E. Perlman, Catherine M. Ambler, Mary Catherine Mack, Barbara Brockhurst, Christopher J. H. Porter	2014	18
16	Synthesis and Pharmacological Evaluation of N,N‘-Diarylguanidines as Potent Sodium Channel Blockers and Anticonvulsant Agents Journal of Medicinal Chemistry ·N. Laxma Reddy, Wenhong Fan, Sharad S. Magar, Michael E. Perlman, Elizabeth A. Yost, Lu Zhang, David Berlove, James B. Fischer, Kathy Burke-Howie, Teresa Wolcott, Graham J. Durant	1998	16
17	Synthesis, molecular symmetry, and chemical reactivity of C-aryl-substituted phosphoraziridines The Journal of Organic Chemistry ·Michael E. Perlman, Thomas J. Bardos	1988	14
18	Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623 Molecular Pharmaceutics ·Claire L. McEvoy, Natalie L. Trevaskis, Orlagh M. Feeney, Glenn A. Edwards, Michael E. Perlman, Catherine M. Ambler, Christopher J. H. Porter	2017	14
19	In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate. Molecular Pharmacology ·Barry S. Selinsky, Michael E. Perlman, R E London	1988	13
20	Solution-Phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers Bioorganic & Medicinal Chemistry Letters ·Seetharamaiyer Padmanabhan, Ruth C. Lavin, Paresh Thakker, Jinqing Guo, Lu Zhang, Deke Moore, Michael E. Perlman, Cassandra Kirk, Deborah Daly, Kathy J Burke-Howie, Teresa Wolcott, Suchitra Chari, David Berlove, James B. Fischer, William F. Holt, Graham J. Durant, Robert McBurney	2001	10

About Michael E. Perlman

Michael E. Perlman is a scholar working on Molecular Biology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Spectroscopy, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (5 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Ion channel regulation and function (4 papers), Synthesis and Catalytic Reactions (4 papers), HIV/AIDS drug development and treatment (4 papers), Drug Solubulity and Delivery Systems (3 papers) and Advanced NMR Techniques and Applications (3 papers). The work is most often cited by research in Developmental Neuroscience (108 citations), Pathology and Forensic Medicine (428 citations), Emergency Medicine (208 citations), Pharmaceutical Science (102 citations) and Cardiology and Cardiovascular Medicine (313 citations). Michael E. Perlman has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert E. London, Charles Steenbergen, Elizabeth Murphy, D. G. Davis, Donald G. Davis, Ronald W. Clark, M J Bamberger, Tamara A. Sutfin, Thomas Sand and Patricia G. Cosgrove. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Circulation Research, Bioorganic & Medicinal Chemistry Letters and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact